Four cases of dyskinesia attributable to treatment with 4-20 mg. of haloperidol daily for more than a year are reported. Two cases involved temporary oral-facial dyskinesias and the others a more persistent complex mixture of neurological features. The possibility that tardive dyskinesia may be associated with the butyrophenones in addition to other antipsychotic agents should be considered, the authors believe.Abstract Teaser